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agreement was found between the experimental and the-
oretical results with respect to the mechanism of binding 
and binding constants. Results indicated that the order of 
propensity of the complexes to BSA was as follows: [In(L)
NO3] > [Ga(L)NO3] > [Al(L)NO3].
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Introduction
Schiff base complexes are important class of metal com-
plexes in medicinal and pharmaceutical fields. In recent 
years, they have shown biological applications includ-
ing excellent antibacterial, antifungal [1] and anticancer 
properties [2]. Diamino-tetradentate Schiff base ligands 
and their complexes have been used as biological models 
in understanding the structure of biomolecules and bio-
logical processes. Metal complexes containing N2O2 Schiff 
base ligands have been attracted some attention in biologi-
cal systems [3]. Most of the studies have been done on the 
transition metal complexes, but main group metals espe-
cially group 13 metals were not considered widely [4–7]. In 
recent years, the role played by aluminum in causing Alz-
heimer’s disease has been clear. The accumulation of alu-
minum in the brain causes Alzheimer’s disease [8]. Thus, 
aluminum and its complexes (such as Schiff base com-
plexes) and their biological activity attract some attentions 
[9]. Other group 13 Schiff base complexes [gallium(III) 
and indium(III)] [10] are proven to have antimalaria prop-
erties [11–13], however, Ga(III) Schiff base complexes 
were previously reported as potential positron emitting 
Abstract In this work, three new water-soluble 
aluminum(III), gallium(III) and indium(III) Schiff base 
complexes; [M(L)NO3], where L denotes; N,N′-bis(5-
sulfosalicyliden)-1,2-phenylendiamin (5-SO3-1,2-salo-
phen); were synthesized and characterized by UV–Vis 
spectroscopy, 1H NMR, FT-IR, thermal gravimetry and 
C.H.N analyses. Also, the optimized structure and the 
energy level of the frontier orbitals for the complexes were 
computed using B3LYP/LANL2DZ method and 6–311g 
basis set. The interaction of these complexes with bovine 
serum albumin (BSA) was studied by fluorescence and 
UV–Vis techniques. The results showed that the intrinsic 
fluorescence of BSA was quenched by adding the com-
plexes, which was rationalized in terms of the dynamic 
quenching mechanism. Binding constants, Stern–Volmer 
constants, number of binding sites and binding stoichi-
ometry were determined by fluorescence method. Further-
more, the thermodynamic parameters calculating by van’t 
Hoff equation, indicated that the binding mode is entropy 
driven and enthalpically disfavored. Site marker competi-
tive experiments revealed that these complexes can bind to 
the subdomain IIIA (site II) of BSA. Based on the Förster 
theory of non-radiation energy transfer, the efficiency of 
energy transfer and the distance between the donor (BSA) 
and the acceptor (complex) were obtained. Also, the syn-
chronous fluorescence spectra displayed that the micro-
environment of the tyrosine residues was not apparently 
changed. Finally, the binding of the complexes to BSA 
was modeled by molecular docking method. Excellent 
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(PET) radiopharmaceuticals with utility as myocardial per-
fusion imaging agents [14].
Serum albumins are the most abundant proteins in the 
plasma. The most important property of this group of pro-
teins is that they serve as a depot protein and as a trans-
port protein for many drugs and other bioactive small mol-
ecules [15]. Many drugs and bioactive molecules bind to 
albumin as carrier. Then, it is necessary and important to 
study the interaction of synthetic compounds as drug with 
these proteins [16]. Albumins from blood plasma bind with 
pyridoxal phosphate, cysteine, glutathione, Schiff base 
ligands [17], various metal ions such as Cu(II), Ni(II), 
Mn(II), Co(II), Hg(II), Ga(III), metal complexes [18] and 
metallothionein(a metal-binding protein) [19, 20].
Most ligands that are specifically designed for water sol-
ubility contain hydrophilic groups such as phosphonium, 
sulfonate and carboxylate moieties to increase the solubil-
ity of these compounds in water [21].
Fluorescence spectroscopy is a powerful method for the 
study of the interaction of chemical and biological systems 
since it allows non-intrusive measurements of substances 
in low concentration under physiological conditions. This 
technique is one of the most important methods to study 
the interaction between drugs and proteins. The spectral 
changes observed on the binding of fluorophores with 
proteins are an important tool for the investigations of the 
topology of binding sites, conformational changes and 
characterization of substrate to ligand binding. Here, the 
quenching of the intrinsic tryptophan fluorescence of BSA 
used as a tool to study the interaction of the metal com-
plexes with this transport protein under physiological con-
dition [22].
In continuing our research on the interaction of transi-
tion metal complexes with BSA and HSA, in this study, 
some new water-soluble group 13 metals [Al(III), Ga(III) 
and In(III)] Schiff base complexes have been synthesized 
to study the effect of metal on the mechanism of binding 
and binding constants of the complexes with bovine serum 
albumin (BSA). Both experimental and theoretical results 
indicated that indium(III) complex more strongly interacted 
with BSA than gallium(III) and aluminum(III). These stud-




All chemicals were used as obtained commercially, without 
further purification. The 1H NMR spectra were recorded by 
Bruker Avance DPX 250MHz spectrometer. UV–Vis meas-
urements were carried out in Perkin-Elmer (LAMBDA 2) 
UV–Vis spectrophotometers. FT-IR spectra were recorded 
by Shimadzu FT-IR 8300 infrared spectrophotometer. 
Elemental analysis was carried out by Thermo Fininngan-
Flash 1200. Thermogravimetric measurements were per-
formed on a Perkin-Elmer Pyris Diamond Model. Melting 
points were determined on a BUCHI 535. Fluorescence 
spectra were carried out on a Perkin-Elmer (LS-45) spec-
trofluorimeter equipped with a thermostat bath at different 
temperatures. All experiments were carried out in triple 
distilled water at pH = 7.4, 100 mM Tris–HCl buffer and 
50 mM NaCl.
Synthesis and characterization
Sodium salicylaldehyde-5-sulfonate monohydrate (sals) 
was synthesized according to the literature procedure [16] 
and the sulfonation was carried out at 100 °C.
Synthesis of N,N′‑bis(5‑sulfosalicyliden)‑1,2‑phenylendia
min (H2L)
1,2-Phenylendiamin(1.0 mmol) in water (20 mL) was 
added dropwise with continuous stirring to a warm etha-
nolic solution of sals (2.0 mmol). The mixture was refluxed 
for 5 h. During this time, a yellow precipitate was formed 
then filtered and washed with cool ether. The resulting yel-
low compound was dried in vacuum at 50 °C.
H2L Yield: 38 % m.p. >250 °C, color: yellow, 
1H NMR 
(250 MHz, DMSO-d6, δ ppm): 13.19 (s, 2H, OH), 8.97 
(s, 2H, N=CH), 6.86–7.94 (m, 10H, Ar–H). FT-IR (KBr, 
cm−1): 3386 ν(O–H), 1620 ν(C=N), 1481 ν(C=C), 1033, 1110, 
1195 ν(SO−3 )
. Anal. Found (Calc.) %: C20H14N2S2O8Na2, 
C: 46.77 (46.34); H: 2.19 (2.33); N: 5.38 (5.40); UV–Vis 
(H2O) λ (nm): 325, 259, 225.
Synthesis of the complexes
A solution of metal(III) nitrate (2 mmol was dissolved in 
minimum amount of water) was added to the stirring solu-
tion of the ligand (H2L) (2 mmol). The mixture was vigor-
ously stirred for 6 h at 40 °C, and then ethanol (5 mL) was 
added and stirring was continued to precipitate the product. 
The resulting powder was collected by filtration, washed 
with ethanol and ether then recrystallized from ethanol and 
dried at 50 °C in vacuum (Scheme 1).
Sodium [(N,N′‑bis(5‑sulfosalicyliden)‑1,2‑phenylendiam
ino)nitrato]aluminate(III) Na2 [Al(5‑SO3‑1,2‑salsophen)
NO3] Yield: 47 %. m.p. >250 °C, color: yellow.
1H NMR 
(250 MHz, DMSO-d6, δ ppm): 8.38 (s, 2H, N=CH), 7.08–
7.76 (m, 10H, Ar–H). FT-IR (KBr, cm−1): 3425 ν(O–H), 
1610 ν(C=N), 1465 ν(C=C), 1388, 820 ν(N–O), 1026, 1110, 
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1180 ν(SO3), 563 ν(M–N), 486 ν(M–O). Anal. Found (Calc.) %: 
(C20H12AlN3Na2O11S2); C: 39.79 (39.55); H: 1.93 (1.99); 
N: 6.66 (6.92); UV–Vis (H2O) λ (nm): 360, 250, 230.
Sodium [N,N′‑bis(5‑sulfosalicyliden)‑1,2‑phenylendiam
ino)nitrato]galliumate(III) Na2 [Ga(5‑SO3‑1,2‑salsophen)
NO3] Yield: 46 %. m.p. >250 °C, color: yellow, 
1H NMR 
(250 MHz, DMSO-d6, δ ppm): 9.46 (s, 2H, N=CH), 6.89–
8.22 (m, 10H, Ar–H). FT-IR (KBr, cm−1): 3425 ν(O–H), 
2950–3075 ν(C–H), 1612 ν(C=N), 1458 ν(C=C), 1382, 825 ν(N–
O), 1026, 1110, 1188 ν(SO3), 543 ν(M–N), 455 ν(M–O). Anal. 
Found (Calc.) %:(C20H12GaN3Na2O11S2); C: 36.81 (36.95); 




NO3] Yield: 58 %. m.p. >250 °C, color: yellow, 
1H 
NMR (250 MHz, DMSO-d6, δ ppm): 9.39 (s, 1H, N=CH), 
6.84–8.22 (m, 10H, Ar–H). FT-IR (KBr, cm−1): 3445 
ν(O–H), 2950–3080 ν(C–H), 1612 ν(C=N), 1460 ν(C=C), 1458, 
1380, 1320, 1020, 815 ν(N=O), 1378 ν(N–O), 1181, 1110, 
1028 ν(SO3), 552 ν(M–N), 480 ν(M–O). Anal. Found (Calc.) %: 
(C20H12InN3Na2O11S2); C: 34.79 (34.55); H: 1.93 (1.74); N: 
5.86 (6.04); UV–Vis (H2O) λ (nm): 370, 250, 225.
Methods
Absorption spectroscopy
Absorption titration was performed using Perkin-Elmer 
(LAMBDA 2) UV–Vis spectrophotometer, equipped 
with a thermostat bath. Temperature kept constant within 
±0.1 °C. Absorption titrations were performed at 280 nm 
at fixed concentration of BSA (1 × 10−5 M), while varying 
the concentration of Schiff base complex. A change in 
absorbance at this wavelength is a convincing evidence for 
the formation of ligand–BSA complex.
Fluorescence titration of BSA with the complexes
2.5 mL of BSA solution (1 × 10−7 M) was poured into 
the fluorescence cell. Emission spectra were recorded 
after each addition (10 µL) of complex solutions 
(1.25 × 10−5 M) in the same buffer at different tempera-
tures (298, 304, and 310 K). The samples were excited at 
280 nm. The observed fluorescence intensities were also 
correlated for dilution.
The reaction time has been studied and the results 
showed that 2 min was enough for the stabilization. So the 
change in fluorescence emission intensity was measured 
within 2 min after each addition of the complex.
Competition reactions between phenylbutazone, ibuprofen 
and complexes for binding to BSA
To identify the binding sites of BSA, displacement of phenylb-
utazone and ibuprofen was followed fluorimetrically. For this 
purpose, an equimolar mixture of BSA 2.5 mL (1 × 10−7 M) 
and phenylbutazone (5 μL, 5.0 × 10−5 M) in 50:50 V/V % 
water/acetone solution was prepared and kept for 1 h and then 
titrated with complex (1.25 × 10−3 M) solution. Similar solu-
tion was prepared that containing 2.5 mL BSA (1 × 10−7 M) 
and 5 μL ibuprofen (5 × 10−5 M in 50:50 V/V % water/ace-
tone) was titrated by complex (1.25 × 10−5 M) solutions.
Synchronous fluorescence
The synchronous fluorescence spectra were achieved 
by scanning simultaneously the excitation and emission 
Scheme 1  Structure of the 
water-soluble Schiff base com-
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monochromator by Perkin-Elmer (LS-45) spectrofluorim-
eter. The synchronous fluorescence spectra only showed the 
tyrosine residue and the tryptophan residue of BSA when 
the wavelength interval (∆λ) is 15 and 60 nm, respectively 
[23].
Computational details
The starting point for geometry optimization was modeled 
with the Gaussian View program, while geometry calcula-
tions were made using the Gaussian 03 set of programs. 
Calculations were performed with B3LYP method as 
implemented in the Gaussian programs [24]. The geome-
tries of these complexes were fully optimized using 6-311 g 
basis set for all atoms and LANL2DZ basis set were per-
formed for In(III) complex.
Molecular docking
The crystal structure of BSA (entrycodes 3V03) was taken 
from the Brook haven Protein Data Bank (http://www.pdb.
org). 3V03 was chosen because of no missing at atoms, no 
crystallized ligand and having reasonable good resolution. 
To get the most stable geometry of Schiff base complexes, 
the structure optimizing calculation was carried out at the 
6–311g level, by employing the Becke three-parameter 
Lee–Yang–Parr (B3LYP) hybrid density functional theory 
using the quantum chemistry software Gaussian 03. The 
structures with the lowest energy were selected for the 
docking study. All flexible ligand docking calculations 
were performed with the MVD program package. Bond-
ing site was chosen by (x = 37.81, y = 19.87, z = 58.18, 
and radius (A) = 13) for BSA to allow the ligands to rotate 
freely, even in their most fully extended conformations. 
The molecular docking program Molegro Virtual Docker 
(MVD) was employed to generate a docked conformation 
of the complexes with BSA [25].
Results and discussion
Characterization of the complexes
FT‑IR spectra
FT-IR spectrum of the ligand exhibited broad medium 
intensity band at 3386 cm−1 which were assigned to the 
phenolic O–H vibration. This band was disappeared via 
complexation to the metal ions. The FT-IR spectra of com-
plexes exhibited absorption bands at around 3430 cm−1 
that was attributed to the presence of the hydrated water. 
Azomethine vibration of the free ligand was observed 
around 1620 cm−1. In the complexes, these bands were 
shifted to the lower frequencies, which suggested the coor-
dination of the ligand to the metal ions through the azome-
thine nitrogen.
A broad peak in the range 1380–1388 cm−1 and a 
medium peak in the range 815–825 cm−1 were assigned 
to the vibration of N‒O bond of NO3− ligand. It has been 
found that the nitrato ligand in [InL(NO3)] complex was 
coordinated bidentately. In the FT-IR spectra of the com-
plexes, the (N=O) (υ1) and υasym(NO2) (υ5) vibrations char-
acteristic of the chelating bidentate nitrate ion appear at ca. 
1458 and 1320 cm−1, respectively. The υsym(NO2) vibration 
(υ2) at ca. 1026 cm
−1 was characteristic of bidentate chelat-
ing nitrate. The frequency separation of the nitrate stretch-
ing fundamentals (υ1–υ5) has been used as a criterion to 
distinguish between mono- and bidentate chelating nitrates. 
The magnitude of this separation (∆υ 148 cm−1 for [In(L)
NO3]) is indicative of bidentate coordination of the nitrate 
ion [26]. The M–O and M–N stretching vibrations usually 
appeared in the region 400–500 and 410–580 cm−1, respec-
tively. The other series of weak bands between 3100 and 
2800 cm−1 were related to C–H modes of vibrations. The 
ring skeletal vibrations C=C were considered in the region 
1440–1481 cm−1 in all the compounds [27].
UV–Vis spectra
The spectrum of the ligand exhibited one band at 225 nm 
that was attributed to π → π* transitions in aromatic 
rings and two bands at 259 and 325 nm were assigned to 
π → π* and n → π* transition, respectively, which were 
attributed to C=N, C=O or S=O groups. The complexes 
showed intense absorptions at 220–370 nm, attributed to 
the π → π* transition in the aromatic rings or azomethine 
groups.
1H NMR spectra
The 1H NMR spectral data of the ligand showed singlet 
signal for the azomethine protons at 8.97 ppm and singlet 
signals for hydroxyl protons at 13.19 ppm. The signals 
of the hydrogens of the aromatic rings were appeared at 
6.86–7.94 ppm. Peak due to OH of the Schiff base was not 
observed after formation of the complex [28].
Thermal analysis
In the thermal investigation, heating rate was suitably 
controlled at 10 °C min−1 under nitrogen atmosphere, 
and the weight loss was measured from the ambient tem-
perature up to 1000 °C. The TG/DTA curves, revealed 
that thermal decomposition of [Al(L)NO3] occurred in 
one step but for [Ga(L)NO3] and [In(L)NO3] decompo-
sition occurred in two steps. For indium complex, first 
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mass loss (Calc. 10 %, found 9.5 %) could be seen at 
180 °C and was attributed to the elimination of the NO3 
group. The second mass loss (Calc. 73 %, found 75 %) 
was observed at 577 °C and was attributed to elimina-
tion of organic part of the complex (C27H16N2O8). The 
results of TGA data for all complexes are summarized in 
Table 1.
Geometry optimization and energies of the complexes
The optimized stable molecular structures of the com-
plexes are shown in Fig. 1. Selected bond lengths and 
bond angles of the compounds are listed in Table 2. To 
check the validity of the method applied, we used the 
X-ray diffraction data of a similar complex to compare 
the optimized structures of the synthesized complexes 
[29].
As is shown in Fig. 1, NO3 ligand coordinated as a 
monodentate ligand in aluminum and gallium complexes 
but as a bidentate ligand in indium complex. Therefore, 
the two first complexes were a five coordinated and 
the third one was six coordinated. Also, bond length of 
nitrate oxygen in indium complex was longer than gal-
lium and aluminum. Optimized structure suggested a 
square planar geometry around central atom with two 
N atoms from diamine moiety and two O atoms of phe-
nolic groups. Therefore, the axial position is occupied by 
nitrate group.
The frontier molecular orbitals played an important 
role in the reactivity of the compounds and in many elec-
tric and optic properties [30]. The difference of the ener-
gies of the HOMO and LUMO; the band gap; served as a 
measure of the excitability of the molecule, the smaller 
the energy easily it would be excited. The 3D plots of 
the HOMO and the LUMO of complexes under study are 
shown in Fig. 2. Large HOMO–LUMO gap automatically 
means high excitation energies for many excited states, a 
good stability and a high chemical hardness for the com-
plex. In Al and Ga complexes, LUMO is on aromatic ring 
through empty π* orbitals, but in In complex LUMO is 
located on the nitrate.
Spectral analysis of complex–BSA interaction
UV–Vis study
The UV–Vis absorption spectra of BSA in the presence 
of various concentrations of gallium(III) complex show 
in Fig. 3. The absorbance of BSA increased with increas-
ing concentration of the complex, which was obvious evi-
dence for formation of the complex between BSA and the 
compound.
The absorption data were analyzed according to Eq. (1).
In this equation, εa, εf and εb correspond to extinction 
coefficient of Aobserved/[BSA], the extinction coefficient for 
the free BSA and extinction coefficient for the complex in 
fully bound form, respectively. In the plot of [complex]/
(|εa − εf|) versus [complex], Kb is the ratio of the slope to 
the intercept (Fig. 4). Kb values are listed in Table 3.
Fluorescence study
To interpret the data from fluorescence quenching stud-
ies, it is important to understand what kind of interac-
tion takes place between the fluorophore (serum albumin) 
and the quencher (complex). Fluorescence quenching 
could proceed via different mechanisms usually classi-
fied as dynamic quenching, static quenching or both static 
and dynamic quenching participates in it simultaneously. 
Dynamic quenching mechanism depends upon diffusion, 
since higher temperatures result in larger diffusion coeffi-
cients, the quenching rate constants are expected to increase 
with increasing temperature. On the other hand, increasing 
temperature is likely to result in lower values of the static 
quenching constants [31]. A valuable feature of the intrin-
sic fluorescence of serum albumins is the high sensitiv-
ity of tryptophan and tyrosine to their local environment. 
Transformations in fluorescence spectra of tryptophan and 
tyrosine are common in response to protein conforma-










Table 1  Thermal analyses data 
for the synthesized complexes




[Al(L)]NO3 150–700 80 85.5 Decomposition of ligand with formation of Al2O3
[Ga(L)]NO3 210–420 51 53 Loss of nitrate and diamine part of ligand
440–600 35 32 Decomposition of rest ligand with formation of Ga2O3
[In(L)]NO3 180–185 10 9.45 Loss of nitrate
490–610 79.83 78.02 Decomposition of ligand with formation of In2O3
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denaturation [32]. So, the intrinsic fluorescence of serum 
albumins can provide considerable information about their 
structure and dynamics, and is often considered in the study 
of protein folding and association reactions. The effect of 
Na2[Ga(5-SO3-1,2-salophen)NO3] on BSA fluorescence 
intensity is shown in Fig. 5. It was obvious that BSA had 
a strong fluorescence emission peak around 342 nm after 
being excited at 280 nm. When a fixed concentration of 
BSA was titrated with different amounts of Na2[Ga(5-SO3-
1,2-salophen)NO3] in 0.001 M Tris–HCl buffer (pH = 7.4), 
a remarkable intrinsic fluorescence decreasing of BSA was 
observed. Similar situations were observed for the other 
complexes.
The fluorescence quenching data are analyzed by the 
Stern–Volmer Eq. (2):
where F0 and F are the fluorescence intensities in the 
absence and in the presence of quencher, KSV is the Stern–
Volmer quenching constant, and [Q] is the concentration 
of quencher (complex). The linear Stern–Volmer plots 
indicated that Eq. (2) is applicable for the present systems. 
The values of KSV represented the relative affinity of [M(L)
NO3] for BSA. These results indicated that the probable 
quenching mechanism is dynamic quenching, because the 
KSV increased with increasing the temperature (Fig. 6). 
The plots of the left hand side of Eq. (3) versus [complex]/










salophen)NO3] (c), sulfur: yel‑
low; sodium: pink; oxygen: red; 
nitrogen: blue; zinc: orange
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The average BSA aggregation number, <J>, potentially 
induced by the complexes can be determined by using 
Eq. (3) (Table 4):
The slope, (<J>) <1, indicated that the complex binding did 
not induce any aggregation on BSA molecules and accordingly 







Determination of the binding constant and the binding site
The relationship between fluorescence quenching inten-
sity and the concentration of quencher can be described by 
Eq. (4) [33]:
where F0 and F are the fluorescence intensities in the 
absence and the presence of the complex, Kb is the appar-
ent binding constant of the complex with BSA, and n is the 
number of binding sites per BSA and [Q] is the quencher 
concentration (complex) (Fig. 8). These results showed that 
Kb increased slightly with increasing the temperatures, but 
n is almost constant, which may be indicated that there was 
molecular binding between [M(L)NO3] and BSA according 
to 1:1 stoichiometry (Table 5).
Binding mode and determination of the thermodynamic 
parameters
The combining properties of the drug and proteins could be 
affected by various weak non-covalent interactions such as 
hydrophobicity, hydrogen bonding and stereo-effect. The 
sign and magnitude of the thermodynamic parameters such 
as ∆G (free energy change), ∆H (enthalpy change), and 
∆S (entropy change) of the reaction were important for the 
study of the interaction forces. To obtain further insights 
into the weak interactions associated with the complexation 
of [M(L)NO3] with BSA, we tried to determine the thermo-
dynamic parameters using the van’t Hoff equation (5) [34]:
where Kb is the binding constant at the corresponding tem-
perature and R is the gas constant. The van’t Hoff plots for 
this interaction are shown in Fig. 9. The enthalpy change 
(∆H) is calculated from the slope of the van’t Hoff rela-
tionship and (∆S) from the intercept. The free energy 
change (∆G) is calculated from Eq. (6) at T = 298 K:
All the thermodynamic parameters are listed in Table 5. 
Sign and magnitude of thermodynamic parameter showed 
host–guest systems that are associated with ∆H > 0 and 
∆S > 0 are driven by the hydrophobic interactions, while 
those with ∆H ≈ 0 and ∆S > 0 by the electrostatic inter-
actions and those with ∆H < 0 and ∆S < 0 by the hydro-
gen bonding or van der Waals interactions [35]. The nega-
tive sign of ∆G proved the spontaneity of the binding of 
[M(L)NO3] with BSA, the positive values of ∆H and 
∆S show that the binding processes are mainly entropy 






= logKb + n log [Q],







(6)G = H − TS.
Table 2  Selected bond lengths (Å) and bond angles (°) by theoretical 
calculations for the compounds at B3LYP/LANL2DZ level of theory
[Al(L)]NO3
 Bond lengths (Å)
  Al–N1 2.013
  Al–N2 2.003
  Al–O3 1.828
  Al–O4 1.824
  Al–O47 1.881
 Bond angles (°)
  N1–Al–N2 80.539
  N1–Al–O3 89.179
  O3–Al–O4 89.900
  N2–Al–O4 89.831
[Ga(L)]NO3
 Bond lengths (Å)
  Ga–N1 2.048
  Ga–N2 2.036
  Ga–O3 1.896
  Ga–O4 1.890
  Ga–O47 1.948
 Bond angles (°)
  N1–Ga–N2 79.964
  N1–Ga–O3 89.715
  O3–Ga–O4 88.326
  N2–Ga–O4 90.731
[In(L)]NO3
 Bond lengths (Å)
  In–N1 2.179
  In–N2 2.193
  In–O3 2.006
  In–O4 1.988
  In–O46 2.373
  In–O47 2.239
 Bond angles (°)
  N1–In–N2 75.724
  N1–In–O3 85.555
  O3–In–O4 96.321
  O46–N45–O47 112.420
  O46–In–O47 57.598
  N2–In–O4 86.184
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is of hydrophobic mode. The same was valid for the other 
complexes.
Site‑selective binding of the complexes on BSA 
by competition reaction between site markers 
and complexes
BSA has two main sites for binding to drugs: (i) site I of 
BSA which tryptophan residue is binding to drugs and (ii) 
site II which tyrosine is located (Fig. 10).
The former shows affinity for warfarin, phenylbutazone, 
etc., whereas the binding pocket of the latter is well suited 
for ibuprofen, diazepam, flufenamic acid, etc. To show the 
[ML] binding to tryptophan residue, we used phenylbuta-
zone and ibuprofen as a well-known site marker for site I 
and site II, respectively. For this purpose, emission spectra 
of ternary mixtures of complex, BSA and site marker were 
measured. The results showed that the quenching of BSA in 
the presence of ibuprofen is very smaller than in its absence 
[36]. This has been typically shown in Fig. 11. Based on 
these results, we deduced that a competition existed for the 
binding of ibuprofen and complexes to site II. Therefore, 
the complexes binding to site II is inhibited by the simul-




































Fig. 2  The frontier molecular orbitals for [M(L)NO3] a M = Al, b M = Ga, c M = In
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it remained almost with no change by the addition of phe-
nylbutazone. It could be concluded that the complexes were 
mainly located in the region of site II (subdomain IIIA) in 
BSA. These results were confirmed by molecular dock-
ing studies. The Kb values in Table 6 are compared with 
the values in Table 5 for the absence and presence of site 
markers.
Energy transfer between the complexes and BSA
In Fig. 5, it also could be found that the fluorescence 
















Fig. 3  The electronic absorption spectra of BSA (1.0 × 10−5 M) 
in the presence of increasing amounts of gallium(III) complex 
(1.25 × 10−3 M) at T = 298 K, [complex]/[BSA] = 0.2, 0.4, 0.6, 0.8, 



















Fig. 4  The plot of [complex]/(εa − εf) versus [complex] for the 
gallium(III) complex at T = 298 K
Table 3  The binding constants and free energy values for the interac-
tion of BSA–Schiff base complex at T = 298 K
Complex 10−5 Kb (M
−1)
[AlL(NO3)] 1.23 ± 0.04
[GaL(NO3)] 5.69 ± 0.65























Fig. 5  The emission spectra of BSA (λex = 280, λem = 342 nm) 
in the presence of increasing amount of [Ga(L)NO3], [complex]/
[BSA] = 0.2, 0.4, 0.6, 0.8, 1.0, 1.2. The slits are 10 nm for excitation 

















Fig. 6  The Stern–Volmer plots of the fluorescence titration of BSA 




















Fig. 7  Determination of the average aggregation number of BSA 
(<J>) in the presence of [Ga(L)NO3] at difference temperatures
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decreased at 340 nm, with an isosbestic point at 380 nm. 
These results indicated that a non-radiative energy transfer 
process took place through dipole–dipole coupling effect 
between BSA and the complex.
There was a spectral overlap between the fluorescence 
emission spectrum of the free BSA and absorption UV–
Vis spectra of the complexes (Fig. 12). As the fluorescence 
emission of protein was affected by the excitation light 
around 280 nm, the spectrum ranging from 300 to 500 nm 
was chosen to calculate the overlapping integral.
The energy transfer efficiency between [M(L)NO3] and 
BSA was studied according to the Förster’s energy trans-
fer theory. The Förster theory shows that energy transfer is 
affected not only by the distance between the acceptor and 
the donor, but also by the critical distance of energy trans-
fer (R0), which can be calculated using Eq. (7) [37]:
where F and F0 are the fluorescence intensities of BSA in 
the presence and absence of quencher, r the donor–acceptor 
distance and R0 is the critical distance where the transfer 
efficiency is 50 %:
In Eq. (8), K2 is the space factor of orientation, N the 
refractive index of the medium, Φ the fluorescence quan-
tum yield of the donor, J is the effect of the spectral over-
lap between the emission spectrum of the donor (BSA) and 
the absorption spectrum of the acceptor (complex), which 
could be calculated in Eq. (9):
where F(λ) is the fluorescence intensity of the donor and 
ε(λ) is the molar extinction coefficient of the acceptor. 
Figure 12 shows the overlap of the UV–Vis absorption 
spectrum of [Ga(L)NO3] with the fluorescence emission 
spectrum of BSA, K2 = 2/3, N = 1.36 and Φ = 0.15 for 
















Table 4  The values of Stern–Volmer quenching constants (Ksv) and 
average aggregation number of BSA molecules (<J>), for the interac-
tion of metal complexes with BSA at different temperatures
Compound T (K) 10−5 Ksv (M
−1) <J>
[AlL(NO3)] 298 0.33 0.17
303 0.67
310 1.31
[GaL(NO3)] 298 3.42 0.28
303 4.05
310 6.55





















Fig. 8  Plot of log(F0 − F)/F versus log[Q]. [BSA] = 1.0 × 10−7 M, 
[Ga(L)NO3] = 1.25 × 10−5 M, [complex]/[BSA] = 0.2, 0.4, 0.6, 0.8, 
1.0, 1.2, 1.4 at difference temperatures
Table 5  Binding constant (Kb), binding site and thermodynamic parameters for the interaction of metal complexes with BSA at different tem-
peratures
Compound T (K) 10−5 Kb (M
−1) Binding sites (n) ∆H (kJ mol−1) ∆S (J mol−1 K−1) ∆G (kJ mol−1)
[AlL(NO3)] 298 0.11 0.63 176.5 ± 13.2 670.9 ± 46.0 −26.2 ± 1.5
303 1.01 0.81
310 6.26 1.03
[GaL(NO3)] 298 1.45 0.87 73.4 ± 11.2 344.0 ± 30.1 −31.4 ± .1.3
303 4.79 1.07
310 7.01 1.27
[InL(NO3)] 298 4.97 0.84 40.1 ± 3.1 243.4 ± 10.2 −33.78 ± 1.8
303 9.84 1.04
310 11.67 1.40
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2 < r < 8 nm and 0.5R0 < r < 1.5R0, the energy transfer 
from BSA to [Ga(L)NO3] occurred with high probability 
(Table 7).
Effect of the complexes on the protein conformation
It was observed that the fluorescence of serum albumins 
comes from the tyrosine, tryptophan and phenylalanine 
residues. The spectrum of BSA was sensitive to the micro-
environment of these chromophores. To study molecular 
environment surrounding of BSA, chromophore synchro-
nous fluorescence spectra could be used. The changes of 
maximum emission wavelength of the tryptophan residues 
will reflect the conformation changes of BSA [38].
Distinction of the difference between excitation wave-
length and emission wavelength (∆λ) reflects the spectra 
of disparate chromophores. Large ∆λ values such as 60 nm 
indicated that the synchronous fluorescence of BSA was 
characteristic of tryptophan residue and those with small 
∆λ values such as 15 nm was characteristic of tyrosine. 
The tyrosine residues and the tryptophan residues of the 
fluorescence spectra of BSA at various concentrations of 
[Ga(L)NO3] are shown in Fig. 13a and b, respectively. It 
is apparent from Fig. 13 that the emission peak of the tryp-
tophan residue (∆λ = 60 nm) showed a gradual quench-
ing and a faint red shift, indicating that the complex was 
located in close proximity to the Trp residues and the polar-
ity near the tryptophan residues was increased and so the 
hydrophobicity was decreased faintly. When the hydro-
phobic part of the complex was close enough to the phe-
nyl moiety of Trp, hydrophobicity near the tryptophan resi-
dues decreased involuntarily. But the emission peak of the 
tyrosine residue (∆λ = 15 nm) showed quenching without 
significant shift, which indicated that mentioned complex 
was close to Tyr residue but had no effect on the conforma-
tion of tyrosine microenvironment. Also, the quenching of 
the fluorescence intensity of tyrosine residues was stronger 
than that of the Trp residue, suggesting that Tyr residues 
contributed greatly to the quenching of the intrinsic fluores-
cence. Similar spectral feature were observed for the inter-
action of the other complexes with BSA.
Molecular docking study
The BSA molecule is made up of three homologous 
domains (I, II, III) that are divided into nine loops (L1–L9) 
by 17 disulfide bonds. Each domain is composed of two 
sub-domains (A and B) (Fig. 10). Intrinsic fluorescence 
of BSA is due to the presence of two tryptophan residues 
(Trp-134 and Trp-212). Trp-134 is located on the surface 
of subdomain IB and Trp-212 located within the hydropho-
bic binding pocket of subdomain IIA [39]. In this study, 
the MVD programs [25] were chosen to examine the bind-
ing mode of the complexes at the active site of BSA. The 
y = -28353x + 102.4












Fig. 9  The van’t Hoff plot of [Ga(L)NO3] at difference temperatures
Fig. 10  The structure of BSA
Fig. 11  Quenching of BSA 
(1.0 × 10−7 M) binding to 
Ga[L] (1.25 × 10−5 M) in the 
a absence of site marker, b 


























































440 J IRAN CHEM SOC (2016) 13:429–442
1 3
docking results showed that the complexes prefers the 
binding pocket of site II (subdomain IIIA), demonstrat-
ing that in free energy point of view the adduct formed by 
binding of the complexes to subdomain IIIA is more stable 
than that formed via interaction of the complexes to subdo-
main IIA. It should be noted that the grid box of docking 
was taken large enough so that it span both binding pock-
ets of IIA and IIIA. However, the binding of the complexes 
to site IIIA produced lower free energy of binding. As it 
is obvious from Fig. 14, the complexes are situated within 
the subdomain IIIA cavity. Furthermore, there are also a 
number of specific hydrogen bonds, due to the presence of 
several polar residues in the proximity of the protein, which 
can play an important role in binding of the complexes to 
BSA via H-bonds. In fact, hydrogen bonding interactions 
can occur between the O, N, H of the Schiff base complex 
and the aminoacid residues of BSA (Fig. 14). The results 
suggested that the formation of hydrogen bonds stabi-
lizes the complex–BSA. The binding energy for the bind-
ing of complexes to BSA found to be −126.79, −130.03, 
−131.00 kJ/mol for [Al(L)NO3], [Ga(L)NO3] and [In(L)
NO3], respectively. These results are very close to those 
obtained by the above-mentioned experimental method.
Aminoacid residues involved in complexes–BSA inter-
actions and binding energy for the best selected docking 
positions are listed in Table 8. It is important to note that 
the interactions between Schiff base complexes and BSA 
were not exclusively hydrophobic in nature since some of 
the residues are in the vicinity of the bound complex.
Conclusions
Three new water-soluble aluminum(III), gallium(III) and 
indium(III) complexes were synthesized and the interac-
tion with BSA was investigated by various methods. A 
fluorescence method for the rapid and simple determina-
tion of the interaction between the complexes and BSA, as 
an important carrier protein, under simulated physiologi-
cal condition of pH 7.4 was provided. The experimental 
Table 6  Binding constants of competitive experiments of Schiff base 
complexes–BSA system
T = 298 K
Compounds Site marker 10−5 Kb (M
−1) R2
[Al(L)NO3] Without 0.11 0.9936
Phenylbutazone 0.08 0.9938
Ibuprofen 0.02 0.9964
[Ga(L)NO3] Without 1.45 0.9922
Phenylbutazone 1.14 0.9929
Ibuprofen 0.95 0.9982
[In(L)NO3] Without 4.97 0.9936
Phenylbutazone 3.85 0.9938
Ibuprofen 1.24 0.9964
Fig. 12  Spectral overlap of [Ga(L)NO3] absorption (a) with BSA 
fluorescence (b)
Table 7  Energy transfer parameters for the interaction of metal com-
plexes with BSA
Compound R0 (nm) r (nm) J (cm
3 L mol−1) E
[AlL(NO3)] 2.47 2.18 2.28 × 10−14 0.51
[GaL(NO3)] 2.63 2.41 1.94 × 10−14 0.48
[InL(NO3)] 2.50 2.47 2.56 × 10−14 0.49
Fig. 13  Synchronous 
fluorescence spectra of 
BSA (1.00 × 10−7 mol L−1) 
with a ∆λ = 15 nm and b 
∆λ = 60 nm in the absence and 
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results indicated that the intrinsic fluorescence of BSA can 
be quenched by complexes through the dynamic quench-
ing mechanism; the binding reaction is spontaneous. The 
binding constants Kb, at 298, 304 and 310 K, were deter-
mined according to a Stern–Volmer equation. Also, it was 
concluded that complex binding did not induce any aggre-
gation on BSA molecules and accordingly proved the 1:1 
stoichiometry for [M(L)NO3]:BSA systems. Experimental 
results by synchronous fluorescence spectra also showed 
that the microenvironment around the tyrosine residues 
Fig. 14  a Pose that the com-
plexes docked in binding site. b 
Complexes docked in the bind-





Table 8  Aminoacid residues involved in the complexes–BSA interaction
Complex Binding energy (kJ mol−1) RMSD List of amino acid
[AlL(NO3)] −126.79 65.77 Ala 489, Arg 409, Arg 484, Asn 390, Glu 382, Gly 430, Gly 433, Ile 387, Leu386, Leu 406, 
Leu 429, Leu 452, Lys 396, Lys 413, Phe 402, Phe 487, Pro 383, Ser 488, Thr 448, Thr 
491, Tyr 410, Val 432
[GaL(NO3)] −130.03 69.56 Ala 489, Arg 409, Arg 484, Asn 390, Glu 382, Gly 430, Gly 433, Ile 387, Leu 386, Leu 406, 
Leu 429, Leu 452, Leu 456, Leu 490, Lys 413, Phe 402, Pro 383, Ser 488, Thr 448, Thr 
491, Tyr 410, Val 432
[InL(NO3)] −131.00 72.56 Ala 489, Arg 409, Arg 484, Asn 390, Glu 382, Gly 430, Gly 433, Ile 387, Leu386, Leu 406, 
Leu 429, Leu 452, Leu 456, Lys 396, Lys 413, Phe 394, Phe 402, Phe 487, Pro 383, Ser 
488, Thr 448, Thr 491, Tyr 410, Val 432
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did not show obvious changes during the binding process. 
Thermodynamic results indicated that the binding process 
was endothermic and essentially entropy driven suggest-
ing that hydrophobic interactions play a significant role in 
the adduct formation. The high affinity of BSA for these 
complexes is clearly evidenced by ∆G values which clari-
fied the role of the albumin as endogenous carrier for these 
complexes in the body. The distance (r) between BSA and 
complex, based on the Förster energy transfer theory, was 
calculated and indicated that energy transfer was highly 
possible. The independent docking studies resulted in 
binding constant and binding mechanism very close to the 
experimental ones. As the aim of this study was the effect 
of different metals on the bonding propensity of the com-
plexes to BSA, Kb values compared in this respect. The 
order of the Kb values was as follows: [In(L)NO3] > [Ga(L)
NO3] > [Al(L)NO3]. So, it is concluded that In(III) complex 
had more propensity to interact with BSA than Ga(III) and 
Al(III). Thus, the results are of great importance towards 
further designing and developing metal(III) complexes and 
assessment of BSA binding as drugs.
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